Fox Run Management L.L.C. Makes New $2.44 Million Investment in Cardinal Health, Inc. $CAH

Key Points

• Fox Run Management L.L.C. has acquired 17,688 shares of Cardinal Health, Inc., valued at approximately $2.43 million, marking this stock as its 17th largest position.
• Analysts show a mixed sentiment as Morgan Stanley maintains an "overweight" rating while Wall Street Zen downgraded the stock from a "strong-buy" to a "buy" rating.
• Cardinal Health reported earnings of $2.08 EPS, beating estimates, but missed revenue expectations with $60.16 billion during the quarter.

Fox Run Management L.L.C. purchased a new stake in Cardinal Health, Inc. (NYSE:CAH - Free Report) during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 17,688 shares of the company's stock, valued at approximately $2,437,000. Cardinal Health accounts for 0.4% of Fox Run Management L.L.C.'s portfolio, making the stock its 17th largest position.

Other large investors have also added to or reduced their stakes in the company. JPMorgan Chase & Co. raised its holdings in Cardinal Health by 40.0% in the 1st quarter. JPMorgan Chase & Co. now owns 4,175,992 shares of the company's stock valued at $575,327,000 after acquiring an additional 1,193,983 shares during the period. Marshall Wace LLP grew its position in shares of Cardinal Health by 154.6% during the 4th quarter. Marshall Wace LLP now owns 3,151,736 shares of the company's stock worth $372,756,000 after purchasing an additional 1,913,892 shares in the last quarter. Northern Trust Corp grew its position in shares of Cardinal Health by 16.2% during the 4th quarter. Northern Trust Corp now owns 3,037,849 shares of the company's stock worth $359,286,000 after purchasing an additional 422,755 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in shares of Cardinal Health by 4.3% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 2,321,797 shares of the company's stock worth $274,599,000 after purchasing an additional 94,768 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD grew its position in shares of Cardinal Health by 3.6% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 1,601,322 shares of the company's stock worth $189,390,000 after purchasing an additional 55,781 shares in the last quarter. Institutional investors own 87.17% of the company's stock.

Cardinal Health Price Performance

Shares of Cardinal Health stock traded up $0.09 during trading on Monday, hitting $149.70. The company's stock had a trading volume of 2,053,757 shares, compared to its average volume of 2,419,123. Cardinal Health, Inc. has a 52 week low of $106.54 and a 52 week high of $168.44. The stock has a market cap of $35.75 billion, a price-to-earnings ratio of 23.21, a price-to-earnings-growth ratio of 1.26 and a beta of 0.67. The stock has a 50-day moving average price of $159.63 and a two-hundred day moving average price of $144.72.

Cardinal Health (NYSE:CAH - Get Free Report) last issued its quarterly earnings results on Tuesday, August 12th. The company reported $2.08 EPS for the quarter, beating analysts' consensus estimates of $2.03 by $0.05. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The business had revenue of $60.16 billion for the quarter, compared to analysts' expectations of $60.91 billion. During the same quarter in the prior year, the firm posted $1.84 earnings per share. The business's quarterly revenue was up .5% compared to the same quarter last year. On average, equities analysts predict that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, October 15th. Shareholders of record on Wednesday, October 1st will be issued a dividend of $0.5107 per share. This represents a $2.04 dividend on an annualized basis and a yield of 1.4%. The ex-dividend date is Wednesday, October 1st. Cardinal Health's dividend payout ratio (DPR) is presently 31.63%.

Analysts Set New Price Targets

A number of research analysts recently issued reports on the stock. Jefferies Financial Group set a $150.00 price objective on shares of Cardinal Health in a research note on Tuesday, August 12th. Leerink Partners decreased their target price on shares of Cardinal Health from $188.00 to $186.00 and set an "outperform" rating on the stock in a research note on Tuesday, August 12th. Citigroup reaffirmed a "neutral" rating and set a $170.00 target price (up previously from $157.00) on shares of Cardinal Health in a research note on Friday, June 13th. UBS Group reaffirmed a "buy" rating on shares of Cardinal Health in a research note on Tuesday, August 12th. Finally, Bank of America boosted their target price on shares of Cardinal Health from $165.00 to $170.00 and gave the stock a "buy" rating in a research note on Tuesday, June 10th. Three investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company's stock. According to MarketBeat, Cardinal Health has an average rating of "Moderate Buy" and a consensus price target of $163.20.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.